Julio Delgado

44PUBLICATIONS
311CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Science, technology and engineering curriculum and pedagogyProject managementHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jun 12, 2026
Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy.

|Jun 08, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.

|Mar 09, 2026
The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.

Elise R A Pennings, Frederick W Thielen, Florence Broussais

|Oct 29, 2025
Operational burden and fragmented implementation in CAR T-cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee.

Nick van Sinderen, Julie Dolva, Caterina Riillo

|Oct 22, 2025
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia.

Ofrat Beyar-Katz, Ohad Benjamini, Julio Delgado

|Sep 24, 2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.

Elise R A Pennings, Anne M Spanjaart, Frederick W Thielen

Pageof 8

Frequent Collaborators

12 joint publications

Valentín Ortiz-Maldonado

11 joint publications

Elias Campo

8 joint publications

Pablo Mozas

8 joint publications

Ferran Nadeu